189 related articles for article (PubMed ID: 17163452)
1. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen.
Jellison ER; Guay HM; Szomolanyi-Tsuda E; Welsh RM
Eur J Immunol; 2007 Jan; 37(1):119-28. PubMed ID: 17163452
[TBL] [Abstract][Full Text] [Related]
2. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
[TBL] [Abstract][Full Text] [Related]
3. Parameters governing exhaustion of rare T cell-independent neutralizing IgM-producing B cells after LCMV infection.
Zellweger RM; Hangartner L; Weber J; Zinkernagel RM; Hengartner H
Eur J Immunol; 2006 Dec; 36(12):3175-85. PubMed ID: 17125146
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
5. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
6. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
7. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections.
Hunziker L; Recher M; Macpherson AJ; Ciurea A; Freigang S; Hengartner H; Zinkernagel RM
Nat Immunol; 2003 Apr; 4(4):343-9. PubMed ID: 12627229
[TBL] [Abstract][Full Text] [Related]
8. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses.
Bocharov GA
J Theor Biol; 1998 Jun; 192(3):283-308. PubMed ID: 9650288
[TBL] [Abstract][Full Text] [Related]
9. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection.
Kamperschroer C; Quinn DG
Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
11. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
12. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
13. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
[TBL] [Abstract][Full Text] [Related]
14. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent.
Silvy A; Lagresle C; Bella C; Defrance T
Eur J Immunol; 1996 Mar; 26(3):517-24. PubMed ID: 8605915
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
16. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
[TBL] [Abstract][Full Text] [Related]
17. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
18. Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection.
Oxenius A; Bachmann MF; Mathis D; Benoist C; Zinkernagel RM; Hengartner H
J Immunol; 1997 Jun; 158(12):5717-26. PubMed ID: 9190921
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
[TBL] [Abstract][Full Text] [Related]
20. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
